{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T07:03:34Z","timestamp":1719299014222},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolism"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.diabet.2017.06.005","type":"journal-article","created":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T19:00:53Z","timestamp":1500318053000},"page":"281-291","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Antenatal antipsychotic exposure induces multigenerational and gender-specific programming of adiposity and glucose tolerance in adult mouse offspring"],"prefix":"10.1016","volume":"44","author":[{"given":"E.","family":"Courty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Gobalakichenane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Muscat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Kazakian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Ledent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Moldes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Blondeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Mitanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Buyse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"F\u00e8ve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2017.06.005_bib0215","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","volume":"8","author":"De Hert","year":"2012","journal-title":"Nat Rev Endocrinol"},{"issue":"Suppl 4","key":"10.1016\/j.diabet.2017.06.005_bib0220","first-page":"8","article-title":"Antipsychotic medications: metabolic and cardiovascular risk","volume":"68","author":"Newcomer","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.diabet.2017.06.005_bib0225","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1192\/bjp.178.5.427","article-title":"Psychosocial characteristics and needs of mothers with psychotic disorders","volume":"178","author":"Howard","year":"2001","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.diabet.2017.06.005_bib0230","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1600-0447.1999.tb00990.x","article-title":"The fertility and fecundity of patients with psychoses","volume":"99","author":"McGrath","year":"1999","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.diabet.2017.06.005_bib0235","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1517\/14656566.2015.1041501","article-title":"Antipsychotic use in pregnancy","volume":"16","author":"Kulkarni","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.diabet.2017.06.005_bib0240","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/archgenpsychiatry.2011.1870","article-title":"Antipsychotics during pregnancy: relation to fetal and maternal metabolic effects","volume":"69","author":"Bod\u00e9n","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.diabet.2017.06.005_bib0245","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1517\/14740338.2014.931368","article-title":"Pregnancy exposure to second-generation antipsychotics and the risk of gestational diabetes","volume":"13","author":"Gentile","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.diabet.2017.06.005_bib0250","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1176\/appi.ajp.2007.06111886","article-title":"Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes","volume":"164","author":"Newport","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.diabet.2017.06.005_bib0255","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1192\/bjp.bp.107.041541","article-title":"Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study","volume":"192","author":"Newham","year":"2008","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.diabet.2017.06.005_bib0260","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4088\/JCP.v66n0406","article-title":"Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study","volume":"66","author":"McKenna","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.diabet.2017.06.005_bib0265","first-page":"3","article-title":"Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study","author":"Sadowski","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.diabet.2017.06.005_bib0270","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/schbul\/sbn107","article-title":"Antipsychotic therapy during early and late pregnancy. A systematic review","volume":"36","author":"Gentile","year":"2010","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.diabet.2017.06.005_bib0275","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00004714-200008000-00002","article-title":"Olanzapine-exposed pregnancies and lactation: early experience","volume":"20","author":"Goldstein","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.diabet.2017.06.005_bib0280","doi-asserted-by":"crossref","first-page":"e94788","DOI":"10.1371\/journal.pone.0094788","article-title":"A prospective cohort study of antipsychotic medications in pregnancy: the first 147 pregnancies and 100 one year old babies","volume":"9","author":"Kulkarni","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.diabet.2017.06.005_bib0285","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.schres.2009.10.011","article-title":"Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference?","volume":"116","author":"Lin","year":"2010","journal-title":"Schizophr Res"},{"key":"10.1016\/j.diabet.2017.06.005_bib0290","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/JCP.0b013e318172b8d5","article-title":"Maternal use of antipsychotics in early pregnancy and delivery outcome","volume":"28","author":"Reis","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.diabet.2017.06.005_bib0295","doi-asserted-by":"crossref","first-page":"h2298","DOI":"10.1136\/bmj.h2298","article-title":"Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study","volume":"350","author":"Vigod","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.diabet.2017.06.005_bib0300","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00213-013-3060-6","article-title":"Effects of prenatal exposure to atypical antipsychotics on postnatal development and growth of infants: a case-controlled, prospective study","volume":"228","author":"Peng","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.diabet.2017.06.005_bib0305","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.tips.2010.07.002","article-title":"Preclinical models of antipsychotic drug-induced metabolic side effects","volume":"31","author":"Boyda","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.diabet.2017.06.005_bib0310","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1651-2227.2004.tb00236.x","article-title":"The developmental origins of chronic adult disease","volume":"93","author":"Barker","year":"2004","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.diabet.2017.06.005_bib0315","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ecl.2005.09.006","article-title":"Developmental origins of adult metabolic disease","volume":"35","author":"Simmons","year":"2006","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.diabet.2017.06.005_bib0320","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJMra0708473","article-title":"Effect of in utero and early-life conditions on adult health and disease","volume":"359","author":"Gluckman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabet.2017.06.005_bib0325","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2174\/15748863113086660061","article-title":"Prenatal exposure of a novel antipsychotic aripiprazole: impact on maternal, fetal and postnatal body weight modulation in rats","volume":"9","author":"Singh","year":"2014","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.diabet.2017.06.005_bib0330","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1177\/0269881108100775","article-title":"Effect of lactational exposure of olanzapine on body weight of mice: a comparative study on neonates of both the sexes during post-natal development","volume":"24","author":"Mishra","year":"2010","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.diabet.2017.06.005_bib0335","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2850.2009.01481.x","article-title":"Antipsychotics in pregnancy","volume":"17","author":"McCauley-Elsom","year":"2010","journal-title":"J Psychiatr Ment Health Nurs"},{"key":"10.1016\/j.diabet.2017.06.005_bib0340","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00213-006-0368-5","article-title":"Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects","volume":"186","author":"Coccurello","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.diabet.2017.06.005_bib0345","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1124\/jpet.108.137240","volume":"326","author":"Coccurello","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.diabet.2017.06.005_bib0350","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/JCP.0b013e3181bfe13e","article-title":"30 days of continuous olanzapine infusion determines energy imbalance, glucose intolerance, insulin resistance, and dyslipidemia in mice","volume":"29","author":"Coccurello","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.diabet.2017.06.005_bib0355","doi-asserted-by":"crossref","DOI":"10.1002\/0471142301.ns0933s52","article-title":"A murine model of atypical antipsychotic-induced weight gain and metabolic dysregulation","author":"Coccurello","year":"2010","journal-title":"Curr Protoc Neurosci"},{"key":"10.1016\/j.diabet.2017.06.005_bib0360","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/1357-2725(94)00056-5","article-title":"Gender differences in drug metabolism regulated by growth hormone","volume":"27","author":"Shapiro","year":"1995","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.diabet.2017.06.005_bib0365","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.lfs.2007.08.009","article-title":"Effect of chronic infusion of olanzapine and clozapine on food intake and body weight gain in male and female rats","volume":"81","author":"Choi","year":"2007","journal-title":"Life Sci"},{"key":"10.1016\/j.diabet.2017.06.005_bib0370","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/0269881106069637","article-title":"Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities","volume":"21","author":"Cooper","year":"2007","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.diabet.2017.06.005_bib0375","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2042-6410-4-5","article-title":"Placental contribution to the origins of sexual dimorphism in health and diseases: sex chromosomes and epigenetics","volume":"4","author":"Gabory","year":"2013","journal-title":"Biol Sex Differ"},{"key":"10.1016\/j.diabet.2017.06.005_bib0380","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/sj.mp.4001729","article-title":"Olanzapine impairs glycogen synthesis and insulin signaling in L6 skeletal muscle cells","volume":"10","author":"Engl","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.diabet.2017.06.005_bib0385","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0091-3057(03)00079-0","article-title":"Induction of hyperglycemia in mice with atypical antipsychotic drugs that inhibit glucose uptake","volume":"75","author":"Dwyer","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.diabet.2017.06.005_bib0390","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/sj.npp.1301142","article-title":"Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysis","volume":"32","author":"Vestri","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.diabet.2017.06.005_bib0395","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.2337\/diabetes.54.5.1552","article-title":"Inhibitory effects of antipsychotics on carbachol-enhanced insulin secretion from perifused rat islets: role of muscarinic antagonism in antipsychotic-induced diabetes and hyperglycemia","volume":"54","author":"Johnson","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2017.06.005_bib0400","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1247\/csf.13012","article-title":"The antipsychotic olanzapine induces apoptosis in insulin-secreting pancreatic \u03b2 cells by blocking PERK-mediated translational attenuation","volume":"38","author":"Ozasa","year":"2013","journal-title":"Cell Struct Funct"},{"key":"10.1016\/j.diabet.2017.06.005_bib0405","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1210\/en.2008-0981","article-title":"Early postnatal nutrition determines somatotropic function in mice","volume":"150","author":"Kappeler","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.diabet.2017.06.005_bib0410","doi-asserted-by":"crossref","first-page":"E462","DOI":"10.1152\/ajpendo.90740.2008","article-title":"Maternal prenatal undernutrition alters the response of POMC neurons to energy status variation in adult male rat offspring","volume":"296","author":"Breton","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.diabet.2017.06.005_bib0415","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejphar.2011.05.076","article-title":"Could maternal perinatal atypical antipsychotic treatments program later metabolic diseases in the offspring?","volume":"667","author":"Guillemot","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.diabet.2017.06.005_bib0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1868-7083-6-1","article-title":"The effects of olanzapine on genome-wide DNA methylation in the hippocampus and cerebellum","volume":"6","author":"Melka","year":"2014","journal-title":"Clin Epigenetics"}],"container-title":["Diabetes & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S126236361730469X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S126236361730469X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T03:33:41Z","timestamp":1564371221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S126236361730469X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S126236361730469X"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2017.06.005","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antenatal antipsychotic exposure induces multigenerational and gender-specific programming of adiposity and glucose tolerance in adult mouse offspring","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabet.2017.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}